Suggestion de sujets dans votre recherche.
Résultat(s) 1 - 18 résultats de 18 pour la requête '"EC 3.2.1.18"', Temps de recherche: 8,79s Affiner les résultats
  1. 1
    Surface-Controlled Sialoside-Based Biosensing of Viral and Bacterial Neuraminidases
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  2. 2
    Microsecond dynamics of H10N7 influenza neuraminidase reveals the plasticity of loop regions and drug resistance due to the R292K mutation
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  3. 3
    Impedimetric Characterization of NanA Structural Domains Activity on Sialoside-Containing Interfaces
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  4. 4
    Ex vivo assays to detect complement activation in complementopathies
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  5. 5
    Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  6. 6
    Producing DFT/MM enzyme reaction trajectories from SCC-DFTB/MM driving forces to probe the underlying electronics of a glycosyltransferase reaction
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  7. 7
    Neuraminidase inhibition primes short-term depression and suppresses long-term potentiation of synaptic transmission in the rat hippocampus
    par Savotchenko, Alina
    Publié dans: Neural plasticity (2015)
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  8. 8
    Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  9. 9
    Impacts of papain and neuraminidase enzyme treatment on electrohydrodynamics and IgG-mediated agglutination of type A red blood cells
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  10. 10
    Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design
    Sujets: “...NLM EC 3.2.1.18...”

    Article en ligne

  11. 11
    Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR)
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  12. 12
    Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  13. 13
    Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  14. 14
    Fluorescent assays to quantitate enzymatic activities yielding as end product an aqueous-insoluble indigo-blue dye
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  15. 15
    The role of sialidase in the development of hypocomplementemia in postinfectious acute glomerulonephritis
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  16. 16
    Highly immunogenic artificial complexes based on synthetic immunopotentiating polyions (artificial antigens and vaccines)
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  17. 17
    Comparison of the antigenicity and tolerance of an influenza aluminium oxide adsorbate vaccine with an aqueous vaccine
    Sujets: “...NLM EC 3.2.1.18...”
    Article

  18. 18
    Antibody formation after vaccination with adsorbed and non-adsorbed A/New Jersey/8/76 influenza vaccines
    Sujets: “...NLM EC 3.2.1.18...”
    Article

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel